225 related articles for article (PubMed ID: 24858057)
21. Vitamin K2 suppresses rotenone-induced microglial activation in vitro.
Yu YX; Li YP; Gao F; Hu QS; Zhang Y; Chen D; Wang GH
Acta Pharmacol Sin; 2016 Sep; 37(9):1178-89. PubMed ID: 27498777
[TBL] [Abstract][Full Text] [Related]
22. Baicalin and Geniposide Inhibit Polarization and Inflammatory Injury of OGD/R-Treated Microglia by Suppressing the 5-LOX/LTB4 Pathway.
Li H; Wang Y; Wang B; Li M; Liu J; Yang H; Shi Y
Neurochem Res; 2021 Jul; 46(7):1844-1858. PubMed ID: 33891262
[TBL] [Abstract][Full Text] [Related]
23. [5-Lipoxygenase/cysteinyl leukotriene pathway is not involved in injury of rat C6 glioma cells induced by oxygen-glucose deprivation].
Huang XQ; Huang XJ; Zhang LH; Chen LL; Lu YB; Zhang WP; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 37(5):456-62. PubMed ID: 18925711
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of human cysteinyl leukotriene 1 receptor gene structure.
Woszczek G; Pawliczak R; Qi HY; Nagineni S; Alsaaty S; Logun C; Shelhamer JH
J Immunol; 2005 Oct; 175(8):5152-9. PubMed ID: 16210619
[TBL] [Abstract][Full Text] [Related]
25. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport.
Moos MP; Mewburn JD; Kan FW; Ishii S; Abe M; Sakimura K; Noguchi K; Shimizu T; Funk CD
FASEB J; 2008 Dec; 22(12):4352-62. PubMed ID: 18779380
[TBL] [Abstract][Full Text] [Related]
26. [Effects of cysteinyl leukotriene receptors on phagocytosis of mouse microglial cells].
Wang X; Lu Y; Zhang W; Wei E; Fang S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):10-18. PubMed ID: 30146806
[TBL] [Abstract][Full Text] [Related]
27. GPR17 mediates ischemia-like neuronal injury via microglial activation.
Zhao B; Wang H; Li CX; Song SW; Fang SH; Wei EQ; Shi QJ
Int J Mol Med; 2018 Nov; 42(5):2750-2762. PubMed ID: 30226562
[TBL] [Abstract][Full Text] [Related]
28. 7,8-Dihydroxyflavone attenuates the release of pro-inflammatory mediators and cytokines in lipopolysaccharide-stimulated BV2 microglial cells through the suppression of the NF-κB and MAPK signaling pathways.
Park HY; Park C; Hwang HJ; Kim BW; Kim GY; Kim CM; Kim ND; Choi YH
Int J Mol Med; 2014 Apr; 33(4):1027-34. PubMed ID: 24535427
[TBL] [Abstract][Full Text] [Related]
29. Rotenone induces neuronal death by microglial phagocytosis of neurons.
Emmrich JV; Hornik TC; Neher JJ; Brown GC
FEBS J; 2013 Oct; 280(20):5030-8. PubMed ID: 23789887
[TBL] [Abstract][Full Text] [Related]
30. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis.
Lötzer K; Spanbroek R; Hildner M; Urbach A; Heller R; Bretschneider E; Galczenski H; Evans JF; Habenicht AJ
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):e32-6. PubMed ID: 12816882
[TBL] [Abstract][Full Text] [Related]
31. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.
Nieves D; Moreno JJ
Biochem Pharmacol; 2006 Oct; 72(8):1022-30. PubMed ID: 16934759
[TBL] [Abstract][Full Text] [Related]
32. Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells.
Kata D; Földesi I; Feher LZ; Hackler L; Puskas LG; Gulya K
Neuroscience; 2016 Feb; 314():47-63. PubMed ID: 26633263
[TBL] [Abstract][Full Text] [Related]
33. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
Sharma JN; Mohammed LA
Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
[TBL] [Abstract][Full Text] [Related]
34. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assays.
Yan D; Stocco R; Sawyer N; Nesheim ME; Abramovitz M; Funk CD
Mol Pharmacol; 2011 Feb; 79(2):270-8. PubMed ID: 21078884
[TBL] [Abstract][Full Text] [Related]
35. Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.
Shi QJ; Xiao L; Zhao B; Zhang XY; Wang XR; Xu DM; Yu SY; Fang SH; Lu YB; Zhang WP; Sa XY; Wei EQ
Brain Res; 2012 Nov; 1484():57-67. PubMed ID: 23000196
[TBL] [Abstract][Full Text] [Related]
36. Increased cysteinyl leukotriene concentration and receptor expression in tonsillar tissues of Chinese children with sleep-disordered breathing.
Shen Y; Xu Z; Huang Z; Xu J; Qin Q; Shen K
Int Immunopharmacol; 2012 Aug; 13(4):371-6. PubMed ID: 22634478
[TBL] [Abstract][Full Text] [Related]
37. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK; Gupta S; Dastidar S; Ray A
Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
[TBL] [Abstract][Full Text] [Related]
38. Tetrandrine suppresses amyloid-β-induced inflammatory cytokines by inhibiting NF-κB pathway in murine BV2 microglial cells.
He FQ; Qiu BY; Li TK; Xie Q; Cui DJ; Huang XL; Gan HT
Int Immunopharmacol; 2011 Sep; 11(9):1220-5. PubMed ID: 21496499
[TBL] [Abstract][Full Text] [Related]
39. Ethanol extract of Cnidium officinale exhibits anti-inflammatory effects in BV2 microglial cells by suppressing NF-κB nuclear translocation and the activation of the PI3K/Akt signaling pathway.
Lee SH; Lee JH; Oh EY; Kim GY; Choi BT; Kim C; Choi YH
Int J Mol Med; 2013 Oct; 32(4):876-82. PubMed ID: 23864034
[TBL] [Abstract][Full Text] [Related]
40. Leukotriene D4 induces cognitive impairment through enhancement of CysLT₁ R-mediated amyloid-β generation in mice.
Tang SS; Wang XY; Hong H; Long Y; Li YQ; Xiang GQ; Jiang LY; Zhang HT; Liu LP; Miao MX; Hu M; Zhang TT; Hu W; Ji H; Ye FY
Neuropharmacology; 2013 Feb; 65():182-92. PubMed ID: 22982445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
